Herriot Tabuteau
CHIEF EXECUTIVE OFFICER at Axsome Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axsome Therapeutics Inc. June 7, 202498.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Axsome Therapeutics Inc. | Option exercise | +4,660 | $4.95 | $23,067 |
| Aug 6, 2026 | Axsome Therapeutics Inc. | Open-market sale | −4,660 | $213.95 | $997,007 |
| Aug 5, 2026 | Axsome Therapeutics Inc. | Option exercise | +45,004 | $4.95 | $222,770 |
| Aug 5, 2026 | Axsome Therapeutics Inc. | Open-market sale | −45,004 | $212.01 | $9,541,298 |
| Jul 1, 2026 | Axsome Therapeutics Inc. | Option exercise | +49,666 | $4.95 | $245,847 |
| Jul 1, 2026 | Axsome Therapeutics Inc. | Open-market sale | −49,666 | $240.25 | $11,932,257 |
| Jun 9, 2026 | Axsome Therapeutics Inc. | Option exercise | +49,670 | $4.95 | $245,867 |
| Jun 9, 2026 | Axsome Therapeutics Inc. | Open-market sale | −49,670 | $241.01 | $11,970,967 |
| Feb 2, 2026 | Axsome Therapeutics Inc. | Option exercise | +32,410 | $8.02 | $259,928 |
| Feb 2, 2026 | Axsome Therapeutics Inc. | Open-market sale | −32,410 | $185.60 | $6,015,296 |
| Jan 7, 2026 | Axsome Therapeutics Inc. | Option exercise | +31,261 | $8.02 | $250,713 |
| Jan 7, 2026 | Axsome Therapeutics Inc. | Open-market sale | −31,261 | $170.38 | $5,326,249 |
| Jan 6, 2026 | Axsome Therapeutics Inc. | Option exercise | +29,450 | $8.02 | $236,189 |
| Jan 6, 2026 | Axsome Therapeutics Inc. | Open-market sale | −29,450 | $172.33 | $5,075,119 |
| Jan 5, 2026 | Axsome Therapeutics Inc. | Option exercise | +78,703 | $8.02 | $631,198 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.